iThera Medical GmbH

iThera Medical GmbH specializes in near-infrared fluorescence imaging systems, specifically the MSOT Frontier and MSOT Acuity Echo. These devices use molecular optical tomography (MSOT) to enable real-time, non-invasive imaging of biological tissues. They are primarily designed for preclinical and clinical research applications, such as cancer detection, monitoring drug delivery, and vascular imaging, by visualizing molecular processes and tissue characteristics.

iThera Medical GmbH is based in Germany, which places its devices under the jurisdiction of the European Union’s regulatory framework. Since the company’s products fall under EU Device Class IIa—indicating moderate risk—they must comply with the EU Medical Device Regulation (MDR). This classification requires adherence to strict manufacturing, performance, and safety standards to ensure their suitability for research and clinical use.

Yes, iThera Medical GmbH’s devices are registered in the EU’s eudamed database. This registry ensures transparency and traceability of medical devices within the European market, allowing authorities, healthcare providers, and researchers to verify the legitimacy and regulatory status of the products. Listing in eudamed is a requirement under the MDR for devices intended for commercial distribution or use in the EU.

iThera Medical GmbH’s devices are classified as EU Device Class IIa, which categorizes them as moderate-risk medical devices. This classification means they must meet specific safety, performance, and clinical evaluation requirements under the EU Medical Device Regulation (MDR). While Class IIa devices pose a lower risk than higher-class devices, they still require rigorous documentation, such as clinical data and risk management files, to demonstrate their safety and effectiveness before market placement.